Additionally, the literature indicates differences in GFAP between GBM tissue and normal brain tissue, positing, for instance, alternative splicing [29] and that autoantibodies for GFAP exist in pathologies such as paraneoplasm [30]. The gene discussed is GFAP; the disease is glioblastoma.